EDSA (STOCKS)

    Edesa Biotech, Inc. Common Shares

    $5.310000
    +0.010000 (+0.19%)
    Prev close: $5.300000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Pardeep Nijhawan
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $53.98M
    Employees
    16
    P/E (TTM)
    -3.95
    P/B (TTM)
    25.85
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Nonoperating Income/Loss $569.35K
    Research and Development $6.06M
    Operating Income/Loss -$11.01M
    Income/Loss From Continuing Operations After Tax -$10.44M
    Income/Loss From Continuing Operations Before Tax -$10.44M
    Income Tax Expense/Benefit $800.00
    Net Income/Loss -$10.44M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$10.44M
    Net Income/Loss Available To Common Stockholders, Basic -$10.44M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$1.35
    Basic Average Shares 15,735,758
    Assets $12.38M
    Current Assets $10.42M
    Noncurrent Assets $1.97M
    Liabilities $2.19M
    Current Liabilities $2.19M
    Noncurrent Liabilities $0.00
    Equity $10.20M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $10.20M
    Liabilities And Equity $12.38M
    Net Cash Flow From Operating Activities -$7.53M
    Net Cash Flow From Operating Activities, Continuing -$7.53M
    Net Cash Flow From Investing Activities $3.99M
    Net Cash Flow From Investing Activities, Continuing $3.99M
    Net Cash Flow From Financing Activities $3.53M
    Net Cash Flow From Financing Activities, Continuing $3.53M
    Net Cash Flow $0.00
    Net Cash Flow, Continuing $0.00
    Comprehensive Income/Loss -$10.34M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$10.34M
    Other Comprehensive Income/Loss -$10.34M